Research location
Barakaldo
Vizcaya, Spain
Advertisement
Research activity in Barakaldo
Vizcaya, SpainCureCurrent currently publishes aggregate city-level research activity for this location: 102 trials and 102 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Barakaldo
101 linked trials · page 1 of 3A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate CancerNCT07287150 · 2026-03-11 · 1 site observation
RECRUITING
Multicenter Prospective Observational Study on Prostate Salvage Using High-dose-rate Brachytherapy.NCT07860528 · 2026-03-11 · 1 site observation
RECRUITING
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as Add-on Therapy to Ocrelizumab, in Participants With Progressive Forms of Multiple Sclerosis (MS)NCT07282574 · 2026-03-10 · 1 site observation
RECRUITING
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple SclerosisNCT07225504 · 2025-11-11 · 1 site observation
RECRUITING
A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical PracticeNCT07284121 · 2025-07-15 · 1 site observation
RECRUITING
Talazoparib Plus Enzalutamide After Progression to Prior ARPi in Metastatic Prostate CancerNCT06582628 · 2024-07-05 · 1 site observation
RECRUITING
Fractionated Stereotactic Radiotherapy Plus Second-generation Antiandrogen for Oligometastatic Castration-resistant Prostate Cancer Patients.NCT07717268 · 2024-05-16 · 1 site observation
RECRUITING
Short Versus Long-term Androgen Deprivation Therapy With Salvage Radiotherapy in Prostate Cancer. URONCOR 0624NCT05781217 · 2023-03-14 · 1 site observation
RECRUITING
Pathological Response After Neoadjuvant Treatment on NSCLCNCT05167487 · 2021-12-13 · 1 site observation
RECRUITING
Optimizing the Use of Aspirin for the Prevention of PreeclampsiaNCT07665853 · 2026-07-01 · 1 site observation
NOT_YET_RECRUITING
Effect of a Postbiotic Intake on Glucose Control and Microbiota Composition of Type 2 Diabetic Subjects: a Randomized Controlled Trial.NCT06448182 · 2025-01-09 · 1 site observation
COMPLETED
A Cross-sectional Study to Assess the Effectiveness and Safety of Ofatumumab (Kesimpta®) in Patients With Relapsing Multiple Sclerosis in the Spanish Clinical PracticeNCT06251986 · 2024-02-26 · 1 site observation
COMPLETED
Characteristics of Sexual Dysfunction in Patients With Lung CancerNCT06018376 · 2023-07-13 · 1 site observation
COMPLETED
An Observational Study of Patients Receiving T-DXd for Treatment of HER2+, and HER2-low Unresectable and/or Metastatic Breast CancerNCT05592483 · 2023-07-07 · 1 site observation
TERMINATED
Three Antidiarrheal Strategies in HER2+/HR+ Early Breast Cancer Patients Treated With Extended Adjuvant NeratinibNCT05252988 · 2022-08-31 · 1 site observation
ACTIVE_NOT_RECRUITING
Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple SclerosisNCT04926818 · 2021-10-05 · 1 site observation
ACTIVE_NOT_RECRUITING
Molecular Screening Method for Preeclampsia (PREMOM)NCT04990141 · 2021-09-23 · 1 site observation
COMPLETED
Open Label Randomized Multicenter to Assess Efficacy & Tolerability of Ofatumumab 20mg vs. First Line DMT in RMSNCT04788615 · 2021-07-23 · 1 site observation
COMPLETED
Anti-SARS-COV2 Vaccination Study in Lung Cancer PatientsNCT05009030 · 2021-05-06 · 1 site observation
COMPLETED
A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson's DiseaseNCT04777331 · 2021-05-05 · 1 site observation
ACTIVE_NOT_RECRUITING
New Adjuvant Trial of Chemotherapy vs Chemo-immunotherapyNCT04564157 · 2021-01-13 · 1 site observation
ACTIVE_NOT_RECRUITING
An Open-label Study Evaluating Ofatumumab Treatment Effectiveness and PROs in Subjects With RMS Transitioning From Fumarate-based RMS Approved Therapies or Fingolimod to OfatumumabNCT04353492 · 2020-07-14 · 1 site observation
COMPLETED
Clinical Utility of Liquid Biopsy in Brigatinib ALK+ PatientsNCT04223596 · 2020-05-04 · 1 site observation
ACTIVE_NOT_RECRUITING
LunG and Melanoma canceR pAtients coVId19 Disease (GRAVID)NCT04344002 · 2020-04-21 · 1 site observation
COMPLETED
NADIM II: Neo-Adjuvant ImmunotherapyNCT03838159 · 2019-05-15 · 1 site observation
ACTIVE_NOT_RECRUITING
Clinical Effect of Ampreloxetine (TD-9855) for Treating Symptomatic nOH in Subjects With Primary Autonomic FailureNCT03750552 · 2019-01-24 · 1 site observation
COMPLETED
Implementation, Effectiveness and Impact of a Value Based Intervention for Patients with Breast or Lung CancerNCT04960735 · 2019-01-01 · 1 site observation
COMPLETED
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MSNCT03650114 · 2018-12-28 · 1 site observation
ACTIVE_NOT_RECRUITING
Study to Evaluate the Superior Efficacy of Cardiac Resynchronization (SyncAVTM) Using the SyncAVTM AlgorithmNCT03961399 · 2018-12-18 · 1 site observation
COMPLETED
A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Participants With HER2-Positive Early Breast CancerNCT03493854 · 2018-06-14 · 1 site observation
COMPLETED
Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Participants With Parkinson's DiseaseNCT03318523 · 2018-01-10 · 1 site observation
TERMINATED
Efficacy and Safety of BIIB033 (Opicinumab) as an Add-on Therapy to Disease-Modifying Therapies (DMTs) in Relapsing Multiple Sclerosis (MS)NCT03222973 · 2017-11-15 · 1 site observation
TERMINATED
A Study to Evaluate the Efficacy and Safety of Semorinemab in Patients With Prodromal to Mild Alzheimer's DiseaseNCT03289143 · 2017-10-04 · 1 site observation
TERMINATED
Nivolumab in the Real World: Analysis of the Expanded Use in Spanish PatientNCT03132493 · 2017-06-01 · 1 site observation
COMPLETED
A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD)NCT03114657 · 2017-03-29 · 1 site observation
TERMINATED
Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS)NCT03085810 · 2017-03-24 · 1 site observation
TERMINATED
Clevidipine in Neurocritical PatientsNCT05168059 · 2017-01-01 · 1 site observation
COMPLETED
Safety and Efficacy of Pf-06650833 In Subjects With Rheumatoid Arthritis, With An Inadequate Response To MethotrexateNCT02996500 · 2016-11-10 · 1 site observation
COMPLETED
Methotrexate Withdrawal Study of Tofacitinib Modified Release Formulation in Subjects With Rheumatoid ArthritisNCT02831855 · 2016-09-01 · 1 site observation
COMPLETED
Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.NCT02792231 · 2016-08-26 · 1 site observation
COMPLETED
Observational Study of Obstructive Lung Disease (NOVELTY)NCT02760329 · 2016-07-25 · 1 site observation
COMPLETED
221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's DiseaseNCT02477800 · 2015-08-13 · 1 site observation
TERMINATED
A Study of Atezolizumab (MPDL3280A) Compared With a Platinum Agent (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Participants With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower110]NCT02409342 · 2015-07-20 · 1 site observation
COMPLETED
A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira®) In Combination With Methotrexate In Subjects With Active Rheumatoid Arthritis (REFLECTIONS B538-02).NCT02480153 · 2015-06-25 · 1 site observation
COMPLETED
Retrospective Data Collection: Post Study Treatment Anticancer Therapy From IMELDA MO22223NCT02383576 · 2015-04-30 · 1 site observation
COMPLETED
Study of Efficacy and Safety in Premenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast CancerNCT02278120 · 2014-11-20 · 1 site observation
COMPLETED
Hepatocellular Carcinoma in HIV-infected PatientsNCT02785835 · 2014-05-01 · 1 site observation
COMPLETED
A Study of Gantenerumab in Participants With Mild Alzheimer DiseaseNCT02051608 · 2014-03-27 · 1 site observation
COMPLETED
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid ArthritisNCT02092467 · 2014-03-14 · 1 site observation
COMPLETED
ASPET Study: An Observational Study of Tarceva (Erlotinib) in First Line in Patients With Advanced Non-Small Cell Lung Cancer Harbouring EGFR Activating MutationsNCT01723878 · 2013-12-30 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.